S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.20 (-1.68%)
AAPL   164.70 (-0.36%)
MSFT   330.14 (-0.14%)
FB   310.46 (-4.31%)
GOOGL   2,820.00 (-0.63%)
AMZN   3,441.71 (-1.86%)
TSLA   1,090.89 (-4.71%)
NVDA   314.25 (-3.83%)
BABA   122.35 (-4.06%)
NIO   38.40 (-1.87%)
CGC   9.94 (-7.19%)
AMD   149.23 (-5.77%)
GE   92.97 (-2.13%)
MU   84.79 (+0.94%)
T   22.22 (-2.67%)
F   19.63 (+2.29%)
DIS   142.02 (-1.99%)
PFE   54.80 (+1.99%)
AMC   30.13 (-11.23%)
ACB   6.01 (-6.39%)
BA   187.80 (-5.08%)
NASDAQ:APLS

Apellis Pharmaceuticals SEC Filings & 10K Form

$43.52
+1.44 (+3.42%)
(As of 12/1/2021 03:59 PM ET)
Add
Compare
Today's Range
$41.87
$44.51
50-Day Range
$30.74
$47.11
52-Week Range
$27.50
$73.00
Volume
87,916 shs
Average Volume
1.06 million shs
Market Capitalization
$3.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.63

Apellis Pharmaceuticals (NASDAQ:APLS) SEC Filings

DateFilerForm TypeView
09/01/2021
3:34 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:07 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2021
7:02 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2021
6:36 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2021
3:04 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2021
5:40 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2021
5:38 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
6:15 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2021
3:58 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
8:48 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
3:02 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:32 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:04 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:03 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:07 PM
Apellis Pharmaceuticals (Issuer)
SCHEIBLER LUKAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
3:06 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
3:46 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2021
4:40 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
5:02 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
5:00 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
5:17 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
6:29 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
4:55 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2021
3:58 PM
Apellis Pharmaceuticals (Issuer)
Brown Victoria L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
4:58 PM
Apellis Pharmaceuticals (Issuer)
Brown Victoria L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
3:16 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
3:14 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
6:30 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2021
3:32 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:45 PM
Apellis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/17/2021
3:12 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:11 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:17 PM
Apellis Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
Form SC 13G/A
02/11/2021
3:18 PM
Apellis Pharmaceuticals (Issuer)
SCHEIBLER LUKAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
3:16 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
3:14 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
3:12 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
3:37 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
9:30 AM
Apellis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/04/2021
6:17 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/04/2021
6:13 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
12:33 PM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/01/2021
3:44 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:43 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:42 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:42 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:40 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:39 PM
Apellis Pharmaceuticals (Issuer)
Apellis Pharmaceuticals (Issuer)
SCHEIBLER LUKAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:38 PM
Apellis Pharmaceuticals (Issuer)
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:37 PM
Apellis Pharmaceuticals (Issuer)
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:36 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:35 PM
Apellis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:35 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:34 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:19 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:18 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
4:15 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2021
3:25 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
3:05 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
3:10 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
6:08 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
6:31 PM
Apellis Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:26 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:25 PM
Apellis Pharmaceuticals (Issuer)
Chan Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:21 PM
Apellis Pharmaceuticals (Issuer)
O'Brien Stephanie Monaghan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:19 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:07 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
4:41 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
3:36 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
3:35 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
3:03 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
4:34 PM
Apellis Pharmaceuticals (Issuer)
SCHEIBLER LUKAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
6:32 PM
Apellis Pharmaceuticals (Issuer)
Perry Nicole D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
6:21 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
5:58 PM
Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
6:13 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
6:12 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
6:11 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
3:01 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
5:32 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2020
6:17 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
4:56 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
4:31 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
3:48 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
3:45 PM
Apellis Pharmaceuticals (Issuer)
Brown Victoria L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:39 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/06/2020
3:37 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2020
3:14 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:36 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
8:46 AM
Apellis Pharmaceuticals (Filer)
Form CT ORDER
08/21/2020
3:36 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:45 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
5:41 PM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2020
3:07 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
4:48 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:41 PM
Apellis Pharmaceuticals (Issuer)
Grossi Federico (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:40 PM
Apellis Pharmaceuticals (Issuer)
Machiels Alec (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
3:39 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
5:07 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2020
4:08 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.